Westfield Capital Management
BPMC

Westfield Capital Management’s Blueprint Medicines BPMC Stock Holding History

Westfield Capital Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-479,467
Closed -$21M – 231
2022
Q4 		$21M Sell
479,467
-324,176
-40% -$15.5M 0.16% 157
2022
Q3 		$53M Sell
803,643
-581,167
-42% -$37.3M 0.42% 93
2022
Q2 		$69.9M Buy
1,384,810
+211,389
+18% +$12.4M 0.55% 64
2022
Q1 		$75M Buy
1,173,421
+74,730
+7% +$5.36M 0.48% 74
2021
Q4 		$118M Sell
1,098,691
-116,662
-10% -$12.2M 0.7% 42
2021
Q3 		$125M Buy
1,215,353
+35,234
+3% +$3.28M 0.75% 36
2021
Q2 		$104M Buy
1,180,119
+51,632
+5% +$4.73M 0.62% 50
2021
Q1 		$110M Buy
1,128,487
+260,420
+30% +$26M 0.68% 46
2020
Q4 		$97.4M Sell
868,067
-192,731
-18% -$20.3M 0.58% 57
2020
Q3 		$98.3M Buy
1,060,798
+8,615
+0.8% +$663K 0.64% 51
2020
Q2 		$82.1M Buy
1,052,183
+27,576
+3% +$1.87M 0.56% 56
2020
Q1 		$59.9M Buy
1,024,607
+253,971
+33% +$16.3M 0.53% 66
2019
Q4 		$61.7M Sell
770,636
-76,323
-9% -$5.71M 0.44% 81
2019
Q3 		$62.2M Buy
846,959
+234,579
+38% +$20.3M 0.5% 70
2019
Q2 		$57.8M Buy
612,380
+145,339
+31% +$12M 0.43% 77
2019
Q1 		$37.4M Sell
467,041
-115,785
-20% -$8.56M 0.28% 117
2018
Q4 		$31.4M Buy
582,826
+73,446
+14% +$4.46M 0.27% 118
2018
Q3 		$39.8M Buy
509,380
+296,400
+139% +$20.6M 0.28% 121
2018
Q2 		$13.5M Buy
+212,980
New +$16.9M 0.1% 197

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Westfield Capital Management's BPMC Position: Q1 2023 in Review

Westfield Capital Management sold out of Blueprint Medicines (BPMC) in Q1 2023, closing a stake of 479,467 shares — an estimated $21M sold.

Westfield Capital Management first reported a position in BPMC in Q2 2018 and held it in 19 quarters. The position peaked at $125M in Q3 2021. 214 funds tracked by Wall St. Rank hold BPMC as of Q1 2023.

  • Westfield Capital Management reported no remaining Blueprint Medicines position as of Q1 2023 after selling out during the quarter.
  • Westfield Capital Management sold 479,467 Blueprint Medicines shares in Q1 2023, an estimated $21M.
  • Westfield Capital Management first reported a position in Blueprint Medicines in Q2 2018 and held it in 19 quarters.
  • Westfield Capital Management's Blueprint Medicines position peaked at $125M in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2023.

Based on Westfield Capital Management's 13F filing for Q1 2023, filed 12 May 2023.